ReviewTherapeutics and clinical risk management2018

Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis.

Yu-Tuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.